(Q37272989)

19 August 2017

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers (English)

1 reference

multicenter clinical trial

19 August 2017

0 references

author

Nazneen Rahman

19

1 reference

19 August 2017

13

Jenny Chang-Claude

0 references

Hanne Meijers-Heijboer

18

Hanne Meijers-Heijboer

0 references

Richard Houlston

9

Richard Houlston

0 references

Katherine L Nathanson

Katherine L Nathanson

16

0 references

Rosalind Eeles

Rosalind Eeles

7

0 references

P. Andrew Futreal

14

P Andrew Futreal

1 reference

19 August 2017

4

Lesley McGuffog

1 reference

19 August 2017

20

Douglas F Easton

1 reference

19 August 2017

17

Michael Stratton

1 reference

19 August 2017

6

Anthony Renwick

1 reference

19 August 2017

1

Deborah Thompson

1 reference

19 August 2017

2

Sheila Seal

1 reference

19 August 2017

11

Jan Klijn

1 reference

19 August 2017

12

Marijke Wasielewski

1 reference

19 August 2017

3

Mieke Schutte

1 reference

19 August 2017

8

Nayanta Sodha

1 reference

19 August 2017

5

Rita Barfoot

1 reference

19 August 2017

Susan Shanley

10

1 reference

19 August 2017

Barbara L Weber

15

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Cancer Epidemiology, Biomarkers & Prevention

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

12

1 reference

19 August 2017

2542-2545

1 reference

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2 is a multiorgan cancer susceptibility gene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2 variants associate with hereditary prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHK2 kinase--a busy messenger.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Cancer risks in BRCA2 mutation carriers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2 1100delC is not a risk factor for male breast cancer population

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2 1100delC and colorectal cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Colorectal cancer and theCHEK2 1100delC mutation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Analysis of familial male breast cancer for germline mutations in CHEK2

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

Increasing evidence that germline mutations inCHEK2 do not cause Li-Fraumeni syndrome

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714971

CHEK2*1100delC and male breast cancer risk in Israel

3 December 2018

1 reference

12 December 2020

Analysis of CHEK2 gene for ovarian cancer susceptibility

1 reference

12 December 2020

Programs for pedigree analysis: Mendel, Fisher, and dGene

1 reference

12 December 2020

Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma

1 reference

12 December 2020

10.1158/1055-9965.EPI-06-0687

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

17164383

1 reference